These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 14635966

  • 1. Treatment of congestive heart failure.
    Butson R.
    J Small Anim Pract; 2003 Nov; 44(11):516. PubMed ID: 14635966
    [No Abstract] [Full Text] [Related]

  • 2. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 3. Treatment of congestive heart failure in dogs.
    Boswood A, Dukes-McEwan J, French A, Little C, Patteson M, Swift S, Smith S, Willis R.
    Vet Rec; 2008 Oct 25; 163(17):520. PubMed ID: 18953081
    [No Abstract] [Full Text] [Related]

  • 4. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Oct 25; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 5. Use of pimobendan in the management of heart failure.
    Fuentes VL.
    Vet Clin North Am Small Anim Pract; 2004 Sep 25; 34(5):1145-55. PubMed ID: 15325474
    [Abstract] [Full Text] [Related]

  • 6. Current use of pimobendan in canine patients with heart disease.
    Boswood A.
    Vet Clin North Am Small Anim Pract; 2010 Jul 25; 40(4):571-80. PubMed ID: 20610012
    [Abstract] [Full Text] [Related]

  • 7. A QUEST begins.
    Oyama MA.
    J Vet Intern Med; 2008 Jul 25; 22(5):1076-8. PubMed ID: 18844829
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 25; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 9. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Jun 25; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of pimobendan in dogs with cardiomegaly caused by preclinical mitral valve disease.
    Boswood A, Smith S, Patteson M.
    Vet Rec; 2011 Feb 26; 168(8):222. PubMed ID: 21493561
    [No Abstract] [Full Text] [Related]

  • 11. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A, McEwan JD, French A, Little C, Swift S, Smith S, Patteson M.
    Vet Rec; 2003 Oct 04; 153(14):439-40. PubMed ID: 14582738
    [No Abstract] [Full Text] [Related]

  • 12. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL, Leech E.
    J Vet Emerg Crit Care (San Antonio); 2012 Aug 04; 22(4):398-408. PubMed ID: 22928748
    [Abstract] [Full Text] [Related]

  • 13. Pharmacotherapy of congestive heart failure: pimobendan, a new approach to inotropic stimulation. Proceedings of a satellite symposium to the Xth European Congress of Cardiology. Vienna, Austria, August 31, 1988.
    J Cardiovasc Pharmacol; 1989 Aug 04; 14 Suppl 2():S1-64. PubMed ID: 2478785
    [No Abstract] [Full Text] [Related]

  • 14. Canine heart disease: progress and promise.
    Oyama MA.
    J Small Anim Pract; 2008 Nov 04; 49(11):549-50. PubMed ID: 19006487
    [No Abstract] [Full Text] [Related]

  • 15. Levosimendan in heart failure after surgical repair of cardiac rupture.
    Torrado H, Ventura JL, Ruiz-Majoral A, Farrero E, Rodriguez-Castro D, Carrio ML, Miralles A.
    Minerva Cardioangiol; 2009 Feb 04; 57(1):137-8. PubMed ID: 19202525
    [No Abstract] [Full Text] [Related]

  • 16. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec 04; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.
    Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J.
    J Small Anim Pract; 2005 Mar 04; 46(3):121-30. PubMed ID: 15789807
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW, Jöns O, Bussadori CM.
    J Am Anim Hosp Assoc; 2006 Mar 04; 42(4):249-61. PubMed ID: 16822763
    [Abstract] [Full Text] [Related]

  • 19. A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.
    Ferasin L, Marcora S.
    Vet Res Commun; 2007 Aug 04; 31(6):725-37. PubMed ID: 17253114
    [Abstract] [Full Text] [Related]

  • 20. Clinical findings and survival time in dogs with advanced heart failure.
    Beaumier A, Rush JE, Yang VK, Freeman LM.
    J Vet Intern Med; 2018 May 04; 32(3):944-950. PubMed ID: 29635788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.